Read Gene SA
WSE:RDG

Watchlist Manager

Read Gene SA

WSE:RDG

Watchlist

Dividends

Discount Rate

Price: 4.9 PLN 1.66%

Market Cap: 57.8m PLN

Have any thoughts about
Read Gene SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 4.9 PLN

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

RDG Alert

Read Gene SA

4.9

+0.08 (+1.66%)

52 Week Range	3.2 6.6
Price Target

We'll email you a reminder when the closing price reaches PLN.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Read Gene SA

What unique competitive advantages
does Read Gene SA hold over its rivals?

What risks and challenges
does Read Gene SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Read Gene SA.

What unique competitive advantages
does Read Gene SA hold over its rivals?

What risks and challenges
does Read Gene SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Read Gene SA.

Provide P/S
for Read Gene SA.

Provide P/E
for Read Gene SA.

Provide P/OCF
for Read Gene SA.

Provide P/FCFE
for Read Gene SA.

Provide P/B
for Read Gene SA.

Provide EV/S
for Read Gene SA.

Provide EV/GP
for Read Gene SA.

Provide EV/EBITDA
for Read Gene SA.

Provide EV/EBIT
for Read Gene SA.

Provide EV/OCF
for Read Gene SA.

Provide EV/FCFF
for Read Gene SA.

Provide EV/IC
for Read Gene SA.

Compare the intrinsic valuations
of Read Gene SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Read Gene SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Read Gene SA compared to its peers.

Compare the P/E ratios
of Read Gene SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Read Gene SA with its peers.

Analyze the financial leverage
of Read Gene SA compared to its main competitors.

Show all profitability ratios
for Read Gene SA.

Provide ROE
for Read Gene SA.

Provide ROA
for Read Gene SA.

Provide ROIC
for Read Gene SA.

Provide ROCE
for Read Gene SA.

Provide Gross Margin
for Read Gene SA.

Provide Operating Margin
for Read Gene SA.

Provide Net Margin
for Read Gene SA.

Provide FCF Margin
for Read Gene SA.

Show all solvency ratios
for Read Gene SA.

Provide D/E Ratio
for Read Gene SA.

Provide D/A Ratio
for Read Gene SA.

Provide Interest Coverage Ratio
for Read Gene SA.

Provide Altman Z-Score Ratio
for Read Gene SA.

Provide Quick Ratio
for Read Gene SA.

Provide Current Ratio
for Read Gene SA.

Provide Cash Ratio
for Read Gene SA.

What is the historical Revenue growth
over the last 5 years for Read Gene SA?

What is the historical Net Income growth
over the last 5 years for Read Gene SA?

What is the current Free Cash Flow
of Read Gene SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Read Gene SA.

RDG

Balance Sheet

Other Current Assets

Read Gene SA
Other Current Assets

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Read Gene SA
Other Current Assets Peer Comparison

Comparables:

MAB

GEN

BIO

URT

SVE

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company		Other Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
R	Read Gene SA WSE:RDG	Other Current Assets zł8.8k	CAGR 3-Years -48%	CAGR 5-Years N/A	CAGR 10-Years N/A
M	Mabion SA WSE:MAB	Other Current Assets zł3m	CAGR 3-Years -9%	CAGR 5-Years 36%	CAGR 10-Years 8%
G	Genomed SA WSE:GEN	Other Current Assets zł360.3k	CAGR 3-Years 1%	CAGR 5-Years -16%	CAGR 10-Years N/A
B	Bioton SA WSE:BIO	Other Current Assets zł2.6m	CAGR 3-Years -4%	CAGR 5-Years -19%	CAGR 10-Years -12%
U	Urteste SA WSE:URT	Other Current Assets N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
S	Synthaverse SA WSE:SVE	Other Current Assets zł1.4m	CAGR 3-Years 11%	CAGR 5-Years 22%	CAGR 10-Years -6%

What is Read Gene SA's Other Current Assets?

Other Current Assets
8.8k PLN

Based on the financial report for Jun 30, 2024, Read Gene SA's Other Current Assets amounts to 8.8k PLN.

What is Read Gene SA's Other Current Assets growth rate?

Other Current Assets CAGR 3Y
-48%

Over the last year, the Other Current Assets growth was 23%. The average annual Other Current Assets growth rates for Read Gene SA have been -48% over the past three years .

Read Gene SA
WSE:RDG

Read Gene SA
Other Current Assets

Read Gene SA
Other Current Assets Peer Comparison

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

See Also

What is Read Gene SA's Other Current Assets?

Other Current Assets
8.8k PLN

What is Read Gene SA's Other Current Assets growth rate?

Other Current Assets CAGR 3Y
-48%

Company

Help

Tools

Stocks

Read Gene SA WSE:RDG

Read Gene SA Other Current Assets

Read Gene SA Other Current Assets Peer Comparison

Competitive Other Current Assets Analysis Latest Figures & CAGR of Competitors

See Also

What is Read Gene SA's Other Current Assets? Other Current Assets 8.8k PLN

What is Read Gene SA's Other Current Assets growth rate? Other Current Assets CAGR 3Y -48%

Company

Help

Tools

Stocks

Read Gene SA
WSE:RDG

Read Gene SA
Other Current Assets

Read Gene SA
Other Current Assets Peer Comparison

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

What is Read Gene SA's Other Current Assets?

Other Current Assets
8.8k PLN

What is Read Gene SA's Other Current Assets growth rate?

Other Current Assets CAGR 3Y
-48%